Result: Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2021

*Physical description scale*:

Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

Journal of medical economics
24, 1 (2021) , 114-122, ISSN: 1941-837X

*DOI*:

10.1080/13696998.2020.1867469

*Result*: Healthcare resource utilization and costs among patients with relapsed and/or refractory multiple myeloma treated with proteasome inhibitors in real-world clinical practice in Germany